Navigation Links
US Script Receives URAC Pharmacy Benefit Management Accreditation
Date:3/13/2008

FRESNO, Calif., March 13 /PRNewswire/ -- US Script, Inc. announced today that as of March 1, 2008, it has received the Pharmacy Benefit Management (PBM) Accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry. Launched in 2007, URAC's PBM Accreditation program delivers the first-ever national standards and service benchmarks for the PBM industry, as well as Continuous Quality Improvement (CQI) processes to improve operations and enhance compliance. US Script is one of only 11 PBMs accredited nationwide.

"By achieving URAC accreditation, US Script has proven that through a pursuit of excellence, any size PBM can deliver a superior level of service and value," said Robert Bagdasarian, president and CEO of US Script. "PBM Accreditation underscores our commitment to quality and safety, and offers a seal of approval that employers, members, and providers can trust."

URAC's Pharmacy Benefit Management Accreditation is achieved by meeting standards and demonstrating industry practices in five areas: organizational quality; customer service, communications and disclosure; pharmacy distribution channels; drug utilization management; and formulary development.

"By applying for and receiving PBM Accreditation, US Script has demonstrated a commitment to quality healthcare," said Alan P. Speilman, URAC president and CEO. "Quality healthcare is crucial to our nation's welfare, and it is important to have organizations that are willing to measure themselves against national standards."

About URAC

URAC, an independent, nonprofit organization, is a leader in promoting health care quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the health care system, and provide a mark of distinction for health care organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the health care industry. For more information, visit http://www.urac.org.

About US Script

US Script is a wholly-owned subsidiary of CenCorp Health Solutions, the specialty division of Centene Corporation. US Script provides clinically sound and fiscally responsible benefit programs that enhance the quality of care. Since 1999, US Script has been working with clients to understand their benefit needs and customizing plan designs, clinical programs, technology strategies, and other services to meet drug management goals. US Script's suite of services includes network claims processing, benefit design consultation, drug utilization review, formulary and rebate management, health state management and outcome assessment, medical and drug data analysis, medical information management, annual benefit plan design review, specialty pharmacy programs, and VIPPS certified mail order pharmacy services via US Script's mail order pharmacy, RxDirect. For more information, visit http://www.usscript.com.


'/>"/>
SOURCE US Script, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Prescription costs rise more than 6 times when patients reach 65 says study of 5M people
2. Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution
3. Hawaiis Premier Physician Management Company, TeamPraxis, Selects Allscripts Electronic Health Record for Statewide Deployment
4. VIDEO from Medialink and General Motors: Electronic Prescriptions Save Lives and Money
5. Non-Medical Use of Prescriptions Linked to Drug Abuse Risk
6. Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians
7. Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products
8. Governor Rendell Tells Congress Prescription for Pennsylvania Will Improve Health Care Climate for Small Businesses
9. Pharmacists Customize Prescriptions By Patient, Day and Dose with onePAC(TM) Packaging
10. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
11. New Jersey Hospital Association Prescription Program Outpaces Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated ... regulations. This is the first time that Coolsculpting is being used for for ... six months to ensure they meet the prescribed body-fat standard, measured by the circumference-based ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... trusted name in the pharmaceutical, medical and food industries. Aside from its GMP ... certification (SIC), providing proof of successfully certified products, services and staff. , Validation ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways ... and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. ... say grilling is their favorite way to cook a hot dog, far outpacing other ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... May 26, 2016 A key ... is the emergence of new treatments. Cardax, a development ... osteoarthritis treatment. The therapy is expected to fulfil large ... UK is conducting studies to develop new treatments for ... the genes involved in osteoarthritis are being investigated, and ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
Breaking Medicine Technology: